¿Qué probar cuando se agotan las opciones?: psoriasis palmoplantar refractaria

• María Dolores Pegalajar-García ^[1] ; Ana Gil-Villalba ^[1] ; Pablo Velasco-Amador ^[1] ; Ricardo Ruiz-Villaverde ^[1]
  1. [1] Servicio de Dermatología y Venereología, Hospital Universitario Clínico San Cecilio, Granada, España
• Localización: Piel: Formación continua en dermatología, ISSN 0213-9251, Vol. 39, Nº. 1 (Enero), 2024, págs. 57-60
• Idioma: español
• DOI: 10.1016/j.piel.2023.06.010
• Títulos paralelos:
  • What to try when options run out?: Refractary palmoplantar psoriasis
• Enlaces
  • Texto Completo Ejemplar
• Referencias bibliográficas
  • Sanchez IM, Sorenson E, Levin E, et al. The efficacy of biologic therapy for the management of palmoplantar psoriasis and palmoplantar pustulosis:...
  • Menter A, Van Voorhees AS, Hsu S. Pustular psoriasis: a narrative review of recent developments in pathophysiology and therapeutic options....
  • Yamamoto T. Guselkumab for the treatment of palmoplantar pustulosis: a Japanese perspective. Clin Pharm. 2021;13: 135–143. https://doi.org/10.2147/CPAA.S266223.
  • Fukasawa T, Yoshizaki-Ogawa A, Enomoto A, et al. Involvement of molecular mechanisms between T/B cells and IL-23: from palmoplantar pustulosis...
  • Blauvelt A, Papp KA, Griffiths CEM, et al. Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab...
  • Terui T, Kobayashi S, Okubo Y, et al. Efficacy and safety of guselkumab in Japanese patients with palmoplantar pustulosis: a phase 3 randomized...
  • Leonardi C, Langley RG, Papp K, et al. Adalimumab for treatment of moderate to severe chronic plaque psoriasis of the hands and feet: efficacy...
  • Bissonnette R, Poulin Y, Guenther L, et al. Treatment of palmoplantar psoriasis with infliximab: a randomized, double-blind placebo-controlled...
  • Menter A, Warren RB, Langley RG, et al. Efficacy of ixekizumab compared to etanercept and placebo in patients with moderate-to-severe plaque...
  • Gottlieb A, Sullivan J, van Doorn M, et al. Secukinumab shows significant efficacy in palmoplantar psoriasis: results from GESTURE, a randomized...